Follow
Dina Kats
Dina Kats
Children's Cancer Therapy Development Institute
Verified email at cc-tdi.org
Title
Cited by
Cited by
Year
Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses
DJ Dowling, EA Scott, A Scheid, I Bergelson, S Joshi, C Pietrasanta, ...
Journal of Allergy and Clinical Immunology 140 (5), 1339-1350, 2017
1502017
Induction of Mycobacterium tuberculosis lipid-specific T cell responses by pulmonary delivery of mycolic acid-loaded polymeric micellar nanocarriers
S Shang, D Kats, L Cao, E Morgun, D Velluto, Y He, Q Xu, CR Wang, ...
Frontiers in immunology 9, 393388, 2018
482018
Quenching of Tryptophan Fluorescence in Unfolded Cytochrome c: A Biophysics Experiment for Physical Chemistry Students
DE Schlamadinger, DI Kats, JE Kim
Journal of chemical education 87 (9), 961-964, 2010
362010
Enabling non-invasive assessment of an engineered endothelium on ePTFE vascular grafts without increasing oxidative stress
B Jiang, L Perrin, D Kats, T Meade, G Ameer
Biomaterials 69, 110-120, 2015
282015
TLR8 agonist encapsulating polymersomes mimic the immunomodulating effect of the live BCG vaccine on neonatal dendritic cells while dramatically enhancing IL-12p70 production
DJ Dowling, EA Scott, A Scheid, I Bergelson, DI Kats, G Sanchez-Schmitz, ...
Journal of Clinical Investigation, 2017
52017
Multi-subunit vaccines to elicit both mhc-and cd1-restricted t cell responses
EA Scott, CR Wang, S Shang, D Kats
US Patent App. 17/645,288, 2022
2022
Multi-subunit vaccines to elicit both MHC-and CD1-restricted T cell responses
EA Scott, CR Wang, S Shang, D Kats
US Patent 11,202,823, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–7